These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28244124)

  • 1. Visceral adiposity predicts post-operative Crohn's disease recurrence.
    Holt DQ; Moore GT; Strauss BJ; Hamilton AL; De Cruz P; Kamm MA
    Aliment Pharmacol Ther; 2017 May; 45(9):1255-1264. PubMed ID: 28244124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of Crohn's disease post-operative care.
    Wright EK; Kamm MA; Dr Cruz P; Hamilton AL; Ritchie KJ; Bell SJ; Brown SJ; Connell WR; Desmond PV; Liew D
    World J Gastroenterol; 2016 Apr; 22(14):3860-8. PubMed ID: 27076772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
    Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn's disease.
    Li Y; Zhu W; Gong J; Zhang W; Gu L; Guo Z; Cao L; Shen B; Li N; Li J
    Colorectal Dis; 2015 Mar; 17(3):225-34. PubMed ID: 25307174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
    Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman S; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM
    Inflamm Bowel Dis; 2019 Feb; 25(3):592-600. PubMed ID: 30215805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound.
    Orlando A; Modesto I; Castiglione F; Scala L; Scimeca D; Rispo A; Teresi S; Mocciaro F; Criscuoli V; Marrone C; Platania P; De Falco T; Maisano S; Nicoli N; Cottone M
    Eur Rev Med Pharmacol Sci; 2006; 10(1):17-22. PubMed ID: 16494106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of Consecutive Fecal Calprotectin Levels in the Perioperative Period and Its Predictive Capacity for Early Endoscopic Recurrence in Crohn's Disease.
    Liu R; Guo Z; Cao L; Wang Z; Gong J; Li Y; Zhu W
    Dis Colon Rectum; 2019 Mar; 62(3):318-326. PubMed ID: 30451756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn's Disease.
    Li T; Click B; Bachour S; Sachs M; Barnes EL; Cohen BL; Contreras S; Axelrad J
    Dig Dis Sci; 2023 Sep; 68(9):3596-3604. PubMed ID: 37548896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
    Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
    J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.
    Baillet P; Cadiot G; Goutte M; Goutorbe F; Brixi H; Hoeffel C; Allimant C; Reymond M; Obritin-Guilhen H; Magnin B; Bommelaer G; Pereira B; Hordonneau C; Buisson A
    World J Gastroenterol; 2018 Feb; 24(5):641-650. PubMed ID: 29434453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease.
    Boube M; Laharie D; Nancey S; Hebuterne X; Fumery M; Pariente B; Roblin X; Peyrin-Biroulet L; Minet-Quinard R; Pereira B; Bommelaer G; Buisson A;
    Dig Liver Dis; 2020 Jul; 52(7):740-744. PubMed ID: 32444250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of adipose tissue for predicting Crohn's disease postoperative endoscopic recurrence and anastomotic ulcer.
    Yang L; Liu G; Zhang Y; Yao B; Wu Q; Peng L; Wang X; Yuan L
    Int J Colorectal Dis; 2023 Jun; 38(1):170. PubMed ID: 37328584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of faecal calprotectin to predict post-operative recurrence in Crohńs disease.
    Herranz Bachiller MT; Barrio Andres J; Fernandez Salazar L; Ruiz-Zorrilla R; Sancho Del Val L; Atienza Sanchez R
    Scand J Gastroenterol; 2016; 51(6):720-6. PubMed ID: 26758472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn's Disease.
    Donnelly M; Driever D; Ryan ÉJ; Elliott JA; Finnegan J; McNamara D; Murphy I; Conlon KC; Neary PC; Kavanagh DO; O'Riordan JM
    Inflamm Bowel Dis; 2024 Sep; 30(9):1517-1528. PubMed ID: 37861366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between high visceral fat area and postoperative complications in patients with Crohn's disease following primary surgery.
    Ding Z; Wu XR; Remer EM; Lian L; Stocchi L; Li Y; McCullough A; Remzi FH; Shen B
    Colorectal Dis; 2016 Feb; 18(2):163-72. PubMed ID: 26391914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Fecal Inflammatory Markers in Crohn's Disease.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Keenan JI; Leach S; Burgess L; Aitchison A; Gorelik A; Liew D; Day AS; Gearry RB
    Inflamm Bowel Dis; 2016 May; 22(5):1086-94. PubMed ID: 26818420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal calprotectin in the prediction of postoperative recurrence of Crohn's disease in children and adolescents.
    Hukkinen M; Pakarinen MP; Merras-Salmio L; Koivusalo A; Rintala R; Kolho KL
    J Pediatr Surg; 2016 Sep; 51(9):1467-72. PubMed ID: 26891835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intestinal resection on quality of life in Crohn's disease.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Sparrow MP; Florin TH; Gibson PR; Debinski H; Gearry RB; Macrae FA; Leong RW; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
    J Crohns Colitis; 2015 Jun; 9(6):452-62. PubMed ID: 25855073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopy.
    Lasson A; Strid H; Ohman L; Isaksson S; Olsson M; Rydström B; Ung KA; Stotzer PO
    J Crohns Colitis; 2014 Aug; 8(8):789-95. PubMed ID: 24418661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.